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Limited data is available on feline leishmaniosis (FeL) caused by Leishmania infantum worldwide. The LeishVet
group presents in this report a review of the current knowledge on FeL, the epidemiological role of the cat in L.
infantum infection, clinical manifestations, and recommendations on diagnosis, treatment and monitoring,
prognosis and prevention of infection, in order to standardize the management of this disease in cats. The consensus
of opinions and recommendations was formulated by combining a comprehensive review of evidence-based studies
and case reports, clinical experience and critical consensus discussions. While subclinical feline infections are common
in areas endemic for canine leishmaniosis, clinical illness due to L. infantum in cats is rare. The prevalence rates of feline
infection with L. infantum in serological or molecular-based surveys range from 0 % to more than 60 %. Cats are able
to infect sand flies and, therefore, they may act as a secondary reservoir, with dogs being the primary natural reservoir.
The most common clinical signs and clinicopathological abnormalities compatible with FeL include lymph node
enlargement and skin lesions such as ulcerative, exfoliative, crusting or nodular dermatitis (mainly on the head or distal
limbs), ocular lesions (mainly uveitis), feline chronic gingivostomatitis syndrome, mucocutaneous ulcerative or nodular
lesions, hypergammaglobulinaemia and mild normocytic normochromic anaemia. Clinical illness is frequently
associated with impaired immunocompetence, as in case of retroviral coinfections or immunosuppressive therapy.
Diagnosis is based on serology, polymerase chain reaction (PCR), cytology, histology, immunohistochemistry (IHC) or
culture. If serological testing is negative or low positive in a cat with clinical signs compatible with FeL, the diagnosis of
leishmaniosis should not be excluded and additional diagnostic methods (cytology, histology with IHC, PCR, culture)
should be employed. The most common treatment used is allopurinol. Meglumine antimoniate has been administered
in very few reported cases. Both drugs are administered alone and most cats recover clinically after therapy. Follow-up
of treated cats with routine laboratory tests, serology and PCR is essential for prevention of clinical relapses. Specific
preventative measures for this infection in cats are currently not available.
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RecommendationsIntroduction and history of feline leishmaniosis
Leishmania infantum (syn. Leishmania chagasi) infec-
tion is found both in the Old and New Worlds with dogs
as the main reservoir. Canine leishmaniosis (CanL) is an
important and complex zoonotic disease whose trans-
mission, pathogenesis, clinical manifestations, diagnosis,
therapy and prevention have been extensively studied
[1, 2]. Conversely, in the last century, the cat was* Correspondence: mariagrazia.pennisi@unime.it
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to Leishmania infection based on two experimental
studies (see Question 5) and on limited numbers of
clinical case reports and histopathological descriptions
of the presence of Leishmania infection in necropsies.
Historically, some studies have used cats for investigat-
ing their potential role as reservoir for Leishmania. Pet
cats living in the same houses where human cases of cu-
taneous or visceral leishmaniosis were diagnosed were
examined for the presence of Leishmania amastigotes in
skin lesions or by post mortem histopathological evalu-
ation of the bone marrow and spleen [3, 4]. In Sicilyrticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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logical and histological examination of spleen, liver and
bone marrow of 120 necropsied cats living in an en-
demic area [5]. The same negative results were obtained
in Egypt when spleen cytology and culture were per-
formed on 28 stray cats, and six of them displaying skin
lesions were negative also from skin [6]. Conversely, in
Jordan, amastigotes were detected in liver and spleen
smears from about 20 % of 78 stray cats [7].
The development of both feline medicine and more
sensitive and specific diagnostic techniques such as sero-
logical and molecular methods has led in recent decades
to an increasing number of documented case reports of
feline leishmaniosis (FeL) and subclinical infections.
However, there is still limited information on epidemio-
logical and clinical aspects of Leishmania infection in
cats which is all derived from descriptive studies, case
reports, information from canine leishmaniosis cases
and personal experience of respected experts. This
means that the current quality of evidence supporting
any recommendation on feline leishmaniosis is low
(grade IV) [8].
In this report the LeishVet group presents an overview
on current knowledge on Leishmania infection in cats.
Moreover, recommendations on the diagnosis, treatment
and monitoring, prognosis and prevention of FeL are
also described in order to standardize the management
of this infection in cats. These were constructed by com-
bining a comprehensive review of evidence-based studies
and case reports, clinical experience and critical consen-
sus discussions. The goal of this review is therefore to
offer the veterinary practitioners an updated approach




1. What species of Leishmania infect cats? What is
their geographical distribution?
Five species within the genus Leishmania have been
identified in cats: Leishmania mexicana, Leishmania
venezuelensis, Leishmania braziliensis and Leishmania
amazonensis in the New World, and Leishmania infan-
tum in both the New and Old Worlds (Table 1). We can
therefore state that cats are likely to be infected by the
same Leishmania species found in humans or other ani-
mals in the same geographic area.
Species, strains, isolates and genetic variants of Leish-
mania spp. found in cats have been characterized by
means of laboratory procedures including electrophor-
esis of isoenzymes upon parasite cultivation, monoclonal
antibodies and molecular methods. The latter mainlycomprise conventional and real time polymerase chain
reaction (PCR) combined with DNA sequence analysis,
restriction fragment length polymorphism (RFLP) or
hybridization of amplified products with specific probes
(Table 1).
In southern European countries, canine and human
leishmaniosis are mainly caused by L. infantum zymo-
deme MON-1 [9]. This occurs also in FeL [10–14], but
zymodemes MON-72 and MON-201 have also been iso-
lated in two single cases from Sicily [10].
2. How is Leishmania transmitted to the cat?
There is no specific information on the transmission
of Leishmania spp. to cats. However, due to the exten-
sive data on vectorial transmission of the Leishmania
group of protozoal parasites to vertebrates, there is no
doubt that the essential mode of transmission is by bites
of infectious phlebotomine sand flies as for other verte-
brate species. This means that in areas where L. infan-
tum is transmitted to dogs, cats are likely to be in
contact with the parasite and can also be potentially in-
fected. The sand fly vectors appear to be more permis-
sive in their blood source preferences than thought
before. Several studies have demonstrated that cats con-
stitute sources of blood for sand flies [15–19]. Moreover,
the experimental demonstration of infectiousness of two
infected cats to sand flies [11, 20] indirectly proves the
ability of the vector to properly complete feeding on cats
and acquire infection.
To date, other routes of transmission including vertical
or horizontal pathways have not been described or dem-
onstrated in cats as they have been in dogs, mice or
humans [1].
Epidemiology including risk factors and geographical
distribution
3. What is the prevalence of L. infantum infection in
endemic regions?
The prevalence of L. infantum infection in cat popula-
tions is commonly estimated by detection of specific
antibodies, and DNA amplification by PCR [21]. Over
the last few decades, many studies have confirmed that
feline Leishmania infection may be relatively common in
areas where CanL is endemic. Seroprevalence ranges
from 0 to 68.5 % and molecular rates of infection range
from 0 and 60.7 % in endemic regions of the Old World
(Table 2). Therefore, a high variability in antibody or
molecular prevalences is evident from published investi-
gations, and this may be due to different levels of en-
demicity, characteristics of the population under study
or differences in diagnostic methodologies including
Table 1 Species of Leishmania identified in cats and geographical areas of description
Species Country (area) Method Global distribution Reference
Leishmania amazonensis Brazil (Mato Grosso do Sul state) ILMA South America [73]
Leishmania braziliensis Brazil (Belo Horizonte city) PCR and hybridization Central and South America [92]c
Brazil (Rio de Janeiro city) MLEE [74]
France (French Guiana) PCR and sequencing [93]d
Leishmania infantum Iran (Fars and East Azerbaijan provinces) PCR and MLEE China, Middle East, Mediterranean basin,
and Central and South America
[94]
Italy (Imperia, Liguria) PCR-RFLP [26]
Italy (Messina, Sicily) MLEE [10]
Italy (Lipari island, Sicily) MLEE and PCR-RFLP [11]
Switzerlanda PCR and sequencing [50]
France (Alpes-Maritimes) MLEE [12]
Spain (Barcelona) PCR and sequencing [29]
Spain (Madrid community) PCR and sequencing [33, 78]
Spaina ILMA [68]
Spain (Mallorca)b PCR-RFLP [95]
Portugal (Lisbon region) PCR and sequencing [96, 97]
Portugal (Lisbon and Algarve regions) PCR and sequencing [98]
Greece (Thessaly and Macedonia) PCR and sequencing [99]
Brazil (Cotia, São Paulo state) PCR and sequencing [100]
Brazil (Rio de Janeiro) PCR and hybridization [101]
Brazil (Andradina, São Paulo state) PCR and sequencing [102, 103]
Brazil (Araçatuba, São Paulo state) PCR and sequencing [104]
Leishmania mexicana USA (Texas) MLEE North and Central America [75]e
USA (Texas) PCR and sequencing [76]
Leishmania venezuelensis Venezuela (Barquisimeto city) MLEE and ILMA South America [105]
aNo data available on the exact origin; bFeral cats; cSubgenus Viannia (species L. braziliensis geographically assumed); dL. braziliensis complex (species L. braziliensis
reasonably assumed; Leishmania peruviana species geographically excluded); eL. mexicana complex; ILMA: immunolabelling with monoclonal antibodies; MLEE:
multilocus isoenzyme electrophoresis; PCR: polymerase chain reaction; RFLP: restriction fragment length polymorphism
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validated the serological techniques in cats by using
feline positive control sera obtained from cats with clin-
ical illness confirmed by isolation and negative control
sera from a substantial number of cats from non endemic
areas [22–25].
However, it is important to highlight that clinical ill-
ness and subclinical infection in cats are less frequently
reported than in their canine counterparts. In fact, the
seroprevalence of Leishmania infection in cats is lower
than in dogs from the same locations [23, 26–28] and a
lower PCR prevalence in cats than in dogs is also reported
from similar geographical areas [29]. Immune responses
leading to natural feline resistance might account for the
observed differences in the prevalence of infection in cats
as compared to dogs. Studies evaluating Leishmania spe-
cific cellular immunity tests in cats could better estimate
infection, but they are still lacking in cats [22].
Limited epidemiological studies have reported signifi-
cant association between L. infantum infection diagnosedby serology or PCR and seasonality [24], altitude [30],
rural habitat [23], outdoor lifestyle [12], male gender [23,
31, 32] and adult age [23, 24, 32, 33]. Feline L. infantum
coinfections with feline leukemia virus (FeLV), feline im-
munodeficiency virus (FIV), feline coronavirus (FCoV)
and/or Toxoplasma gondii have been reported in the lit-
erature [24, 25, 31, 33–37], but a significant association
was found only between L. infantum positivity (molecular
or serological) and FIV [25, 33, 35].
4. What is the epidemiological role of L. infantum
infected cats?
Domestic dogs are considered the only known pri-
mary reservoir for L. infantum infection [38]. It has
been considered for a long time that cats did not play
any role in the epidemiology of L. infantum in endemic
areas. This view was directed by the facts that, for a
long period, very few cases of clinical leishmaniosis
were described in cats as compared to dogs, and that
Table 2 Prevalence of Leishmania infantum infection in cats in the Old World (countries listed in geographical order from East to West)




PCR prevalence (sample) Combined prevalence
of infection
Prevalence of clinical
signs in positive cats
Reference
Iran (Fars and East Azerbaijan
provinces)
40 (stray) 27.5 % (IFAT and
DAT)
NA NA NA [27]
Iran (Fars and East Azerbaijan
provinces)
40 (stray) NA 7.5 % (liver and spleen) 10.0%a 25.0 % (cutaneous) [94]
Israel (Jerusalem) 104 (mainly
stray)
6.7 % (ELISA) NA NA 14.3%b (cutaneous) [30]
Egypt (Ismailia governorate) 80 (stray) 3.8 % (IHAT) NA NA NA [106]
Egypt (Suez governorate) 28 (stray) 3.6 % (IHAT) NA NA NA [6]
Egypt (Giza governorate) 60 (mixed) 10.0 % (IHAT) NA NA NA [4]
Greece (Thessaloniki) 284 (stray) 3.9 % (ELISA) NA NA 0.0 % [107]
Greece (Thessaloniki) 389 (stray/feral) 21.6 % (IFAT) NA NA 19.0 % (compatible) [108]
Greece (Macedonia and
Thessaly)
100 (domestic) 11.0 % (IFAT and
ELISA)
41.0 % (skin, bone marrow,
blood and conjunctiva)
46.0 %c 39.1 % (cutaneous,
ocular or systemic)
[88, 99]
Albania (Tirana surroundings) 146 (stray) 0.7 % (IFAT) 0.0 % (blood) 0.7 % 0.0 % [109]
Italy (Sicily) 93 (mixed) 59.1 % (IFAT) NA NA 0.0 % (cutaneous) [35]
Italy (Catania and Messina
provinces, Sicily)
89 (mixed) 68.5 % (IFAT) 60.7 % (blood) 85.4 % NAb [32]
Italy (Liguria and Tuscany) 110 (domestic) 0.9 % (IFAT) NA NA 0.0 % [26]





Italy (Ischia island, Campania) 95 (mixed) 9.5 % (IFAT) 5.3 (blood), 0.0 %
(bone marrow)
13.7 % 0.0 % [77]
Italy (Calabria and Sicily) 431 (mixed) 6.9 % (IFAT) 7.8 % (blood), 11.7 %
(lymph node), 16.7 %
(conjunctival swabs)
13.9 % NAe [24]
Italy (Greater Milan) 233 (stray) 25.3 % (IFAT) 0.0 % (blood) 25.3 % 79.7 %
(heterogeneous)b
[111]
France (Nice surroundings) 97 (stray) 12.4 % (WB) NA NA 0.0 % [12]
Spain (Barcelona and Girona
provinces)
117 (domestic) 1.7 % (ELISA) NA NA NA [112]
Spain (Aragon) 50 (domestic) 42.0 % (DAT) NA NA 100 % (immune
dysfunction)
[113]
Spain (Catalonia and Mallorca
island)
445 (mixed) 5.3–6.3 %
(ELISA)f
NA NA NAb [22]
Spain (south) 183 (domestic) 28.3–60.0 %
(IFAT)f
25.7 % (blood) 70.6 % NA [114]
Spain (Barcelona) 100 (domestic) NA 3.0 % (blood) NA 100 % (ND) [29]
Spain (Madrid community) 233 (domestic) 1.3–4.3 %
(IFAT)f
0.4 % (blood) 1.7–4.7%f 66.7 %
(heterogeneous)b
[78]
Spain (Ibiza island) 105 (stray/
shelter)
13.2 % (ELISA) 8.7 % (blood) 15.4 % 25.0 % (cutaneous)g [25]
Spain (Mallorca island) 86 (stray/feral) 15.7 % (WB) 26.0 % (blood) 25.6 % 0.0 % [95]
Spain (Madrid community) 20 (breeding
cats)
15.0 % (IFAT) NA NA 0.0 % [115]




346 (stray) 3.2 % (IFAT) 0.0 % (blood) 3.2 % 9.1 % (compatible)b [34]
Portugal (Lisbon region) 23 (stray) 20.0 % (IFAT) 30.4 % (blood) 34.8 % 0.0 % (compatible) [96]
Portugal (northeast) 316 (domestic) 2.8 % (ELISA
and DAT)
NA NA 11.1 % (ND)b [23]
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(Continued)
Portugal (Lisbon region) 180 (stray) 0.6 % (IFAT) NA NA 0.0 % (compatible) [116]
Portugal (Lisbon region) 142 (domestic) 1.3 % (IFAT) 20.3 % (blood) 20.4 % NA [97]
Portugal (North and Centre
regions)
320 (domestic) NA 0.3 % (blood) NA 0.0%b [117]
Portugal (Lisbon and Algarve
regions)
649 (mixed) NA 9.9 % (blood) NA 27.3 % (compatible)b [98]
Portugal (Algarve) 271 (mixed) 3.7 % (DAT) NA NA NA [118]
aPCR results in combination with those from liver and spleen touch smears and cultures; bNo statistical association between clinical status and prevalence of infection/
exposure; cNegative results of lymph node, bone marrow, skin and conjunctiva cytology; dPCR performed only for 11 seropositive cats; eStatistical association between
clinical status and both seroprevalence and combined prevalence; fDifferent prevalences obtained with different ELISA techniques or IFAT cut off; gStatistical association
between clinical status and seroprevalence; DAT: direct agglutination test (cut-off titre: 1:100 or 1:800); ELISA: enzyme-linked immunosorbent assay (different techniques);
IFAT: immunofluorescence antibody test (cut-off titre ranging from 1:2 to 1:100); IHAT: indirect haemagglutination test (cut-off titre: 1:32); NA: not assessed/available; ND:
clinical signs not described; PCR: polymerase chain reaction; WB: western blot
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mental infection [39].
This interpretation has changed, as the concepts of res-
ervoir and susceptibility in infected hosts are now better
understood. The majority of infected dogs does not ex-
hibit clinical signs (at least for a long period), although
they can be infectious to sand flies and consequently serve
as sources of infection. During the last two decades, many
wild mammals have been diagnosed with Leishmania in-
fection by serological and/or molecular methods [40].
However, their role as reliable sources of infection (infec-
tiousness to sand flies, persistent infection) remains un-
known [40]. The recent demonstration that hares can be
persistently infected, infectious to sandflies and a reservoir
for humans in the absence of participation of dogs in the
transmission cycle opens a possible evaluation of the role
of species other than dogs in the epidemiology of L. infan-
tum infections in particular scenarios [41, 42].
Surveys have shown that the percentage of infected
cats is not negligible in some endemic areas (Table 2). In
cats, disease and infection may persist for very long pe-
riods and cats have been shown to be infectious to sand
flies in experimental xenodiagnosis studies both in the
Old and New Worlds. They may, therefore, play some
role in the transmission of L. infantum in regions where
many cats are infected [43].
In cats, infection could be promoted by concurrent im-
munosuppressive infections such as FIV or FeLV [13, 31].
The fact that cats appear to better control the infection and
more rarely manifest the disease is also in favour of a poten-
tial persistent source role of infected individuals. Moreover,
the population of pet and stray cats may be even larger than
that of dogs in some endemic areas [44].
According to the current state of the art, cats are most
likely a secondary reservoir of L. infantum which will
not support persisting infection in a natural setting if the
primary reservoir is absent, e.g. cats alone would not be
responsible for the persistence of L. infantum infection
in an area where disease transmission is possible withabundant competent sand fly vectors, unless infected
dogs are present. The epidemiological role of cats in
the maintenance and transmission of L. infantum
should nevertheless be further investigated [43]. Ques-
tions that need to be addressed include: 1) are cats in-
volved in the transmission of parasite by sand fly
vectors in endemic areas where both infected cats and
dogs are present? 2) how attractive are cats to vector
sandflies? 3) how accessible is the parasite in infected
cats to sand flies?
Experimental Leishmania infection
5. What is known about experimental Leishmania
infection in cats?
Reports on experimental feline infections with Leish-
mania spp. are very scarce. Only two studies have been
reported with different species of the Leishmania dono-
vani complex and were both performed many years ago
[39, 45]. This means that sensitive techniques such as
PCR were not applied for monitoring infected cats. A
third study was conducted more recently in Brazil with
L. braziliensis [46]. Parasitological, serological and clin-
ical details on the experimental studies carried out in
cats are shown in Table 3.
Based on these studies, cats are apparently less suscep-
tible than dogs [47, 48] to the development of disease
after established experimental infection with species of
the L. donovani complex or are even resistant to infec-
tion [15].
In contrast after experimental infection with L. brazi-
liensis, domestic cats develop self-healing chronic cutane-
ous lesions containing parasites as often seen in dogs [49].
Clinical presentation
6. What are the most common clinical findings of FeL
due to L. infantum?
Table 3 Parasitological, serological, and clinical results from experimental Leishmania infections in cats
Cats (n) Leishmania
species
Inoculum Route Sampling Evidence of infection Serology Clinical abnormalities Reference
10 L. infantum
(French strain)
8 × 108 amastigotes (isolated
from a French dog and
maintained by serial passages
in golden hamsters)
IV 2 cats necropsied at 1 h PI,
and weeks 1, 2, 4 and 8 PI
Parasites in spleen, liver, bone
marrow (cytology or culture)
and blood culture from 1 to
8 weeks PI
IFAT: highly positive from 1




5 × 107 amastigotes (isolated
from a human being in Brazil
and maintained by serial
passages in golden hamsters)
IV Cats necropsied at weeks 4
(n= 1), 16 (n= 2) and 24
(n= 2)
Parasites in spleen, liver and
bone marrow (cytology or
culture) from week 4 to 16,
but not at week 24 (no
parasites cultured from blood
at any point)
IFAT: highly positive from
weeks 2 to 24 (rise to





5 × 107 promastigotes (in vitro
cultivation of the above human
strain)
ID (thorax) Pairs of cats necropsies at
weeks 4, 16 and 24; blood
culture at weeks 2, 4, 8, 12,
16 and 24
No parasites detected at
necropsy (bone marrow,
spleen or liver) or blood
cultures
IFAT: positive from weeks 2






from cultures of the splenic
tissue from one IV inoculated cat)
ID Necropsies at 12 weeks PI Negative cultures of different
tissues
ND None [39]
6 + 6 L. donovani
(Kenyan strain)
106 promastigotes IC + IV 2 cats necropsied at
months 1 to 6 PI
Negative on blood, bone
marrow, liver, spleen, kidney





107 promastigotes ID (ear and
nose)
Follow-up for 72 weeks
(n= 9)
Positive parasite cultures from
aspirates of a primary ear lesion
at week 6
ELISA: positive at week 2; all
cats were seropositive at
week 20; after self-healing,
3 cats remained seropositive
until the end of the study
and none of them had
lesion recurrence
Single papules on the ear
and nose as early at week 2;
regression at about 32 and
40 weeks PI in the ear and
nose, respectively; one cat
had lesion recurrence on
the ear 4 months after
self-healing
[46]
4 cats necropsied at
weeks 4, 12, 16 and 24
Negative cultures and imprints
from liver, spleen and bone
marrow
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cent years mainly from European countries where pet
cats typically have a higher standard of health care. In
the New World, other Leishmania spp. are endemic and
may co-infect cats and complicate the clinical picture
[28]. Therefore, we have only reviewed case reports or
case series originally from European countries. A total of
46 clinical cases have been published between 1989 and
2014, where the diagnosis of FeL was confirmed by sero-
logical and/or parasitological methods [11–14, 21, 26,
36, 37, 50–67].
The most common clinical signs reported in FeL in-
clude skin or mucocutaneous lesions and lymph node
enlargement, and they have been described in more than
half of the cases (Table 4). Some cats showed only der-
matological lesions alone [13, 52, 56, 58], while others
with skin lesions showed a combination with systemic
signs [12, 14, 21, 26, 36, 51, 60, 62–64, 68]. Conversely,
other cats did not have any skin detectable lesions on
clinical presentation [11, 36, 50, 54, 55, 57, 66, 69, 70].
The cutaneous and mucocutaneous lesions are de-
scribed in Question 7. Lymphadenomegaly may be soli-
tary or multicentric. Ocular lesions have been reported
in approximately one third of the affected cats. Uveitis,
either unilateral or bilateral (Fig. 1), is the most common
ocular lesion described, with occasionally a pseudotu-
moral granulomatous pattern and eventually progress to
panophthalmitis [50, 53, 55, 64, 69]. Blepharitis andTable 4 Frequency (%) of clinical manifestations described in a
total of 46 case reports and 15 histopathological case
descriptions of feline leishmaniosis from European countries
(1989–2014)
Frequency of clinical manifestations (%)
~50 % 20–30 % <10 %



















Hypothermiaconjunctivitis have also been described in a number of
clinical cases [66, 68, 70]. Amastigotes have been found
by cytology in conjunctival nodules, corneal infiltrates
and aqueous humor, and by histopathology after enucle-
ation of the eye or post mortem even in uveal tissue [50,
53, 55, 64, 69]. Chronic gingivostomatitis is also a com-
mon clinical finding and has been found in about one
fourth of the cats so far studied with leishmaniosis
(Fig. 2) [11, 26, 53, 55, 63, 66, 70]. Nodular lesions are
unfrequently seen on the gingival mucosa or the tongue
[60, 66, 69, 71], where infected macrophages may be vi-
sualized in lesion biopses [60, 69].
Non specific signs such as weight loss, reduced appe-
tite, dehydration, and lethargy also have been reported.
A list of other sporadic clinical manifestations described
includes: pale mucous membranes, hepatomegaly, jaun-
dice, cachexia, fever, vomiting, diarrhea, chronic nasal
discharge, splenomegaly, polyuria/polydipsia, dyspnea,
wheezing, abortion and hypothermia.
The implication of Leishmania as a cause of some of
these clinical signs has been associated with the presence
of the parasite in cytological or histopathological exami-
nations of liver, spleen, lymph nodes, stomach, large
bowel, kidney, oral mucosa, nasal exudate and eye tis-
sues [13, 14, 36, 50, 57, 63, 66, 68, 72]. However, clinical
disease is commonly associated with an impaired im-
munocompetence due to several causes including retro-
viral infections (FIV and FeLV), immunosuppressive
treatment and concomitant debilitating diseases such as
malignant neoplasia or diabetes mellitus [44].
As also found in dogs, FeL does not exclude the possi-
bility of concurrent diseases or co-infections. This fact
may influence the clinical presentation and prognosis.
The cause-effect relationship between various etio-
logical and pathogenic factors is not always easy to es-
tablish [21].
7. What are the most common dermatological findings
of FeL due to L. infantum and to other Leishmania
species?
Cutaneous lesions predominate in the clinical picture
of FeL due to L. infantum. Dermal abnormalities include
nodules, ulcerations or more rarely exfoliative dermatitis.
They are generalized or localized, symmetrical or asym-
metric and may, though less frequently, appear all over
the body in a focal, multifocal, regional or diffuse pattern
[12–14, 26, 36, 37, 51, 52, 56, 58, 60, 62, 64, 68, 70].
Some cats may harbour different types of skin lesions at
the same time or develop them subsequently; they may
coexist with mucocutaneous lesions (Fig. 3). Cutaneous
and mucocutaneous nodules, of variable size, are more
often localized on the head, including eyelids, nose and
lips, or on the distal parts of the limbs. Nodules have
Fig. 1 Clinical findings of feline leishmaniosis due to Leishmania infantum: bilateral uveitis with blood clot (hyphema) in the anterior chamber
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usually small (less than 1 cm), non painful or pruritic
and have a normal, ulcerated or alopecic surface [26, 50,
51, 56, 60, 62–64, 66, 68, 70].
Ulcerations which may be diffuse and superficial or
focal and deep (Fig. 4) are localized on the same body
sites as nodules, and may be complicated by bacterial in-
fections that explain why they are covered by
hemorrhagic crusts and/or purulent material [13, 14, 52,
53, 56, 58, 60–62, 64, 65, 68, 70]. However, ulcerative
dermatitis is sometimes diffuse and can be observed on
the body trunk or on bony prominences [14, 36, 58, 62, 63].Fig. 2 Clinical findings of feline leishmaniosis due to Leishmania infantum:
the tongueIn contrast to CanL, exfoliative dermatitis (Fig. 5) is
rare in the feline disease [36, 52, 68]. Other uncommon
dermatologic presentations include hemorrhagic papules
and nodules where Leishmania amastigotes can be
found [37, 52]. Alopecia (Fig. 6), which is also uncom-
mon in FeL [12, 36, 52, 62, 64], may be associated with
other skin diseases concurring in L. infantum infected
cats such as demodicosis [64]. Mild to severe pruritus is
rare in FeL [58, 64, 65] and in some cases with a pruritic
syndrome other compatible causes co-existed such as
flea allergy [52], pemphigus foliaceus (PF) [56] or neopla-
sia (squamous cell carcinoma) [14].stomatitis and glossitis involving respectively cheeks and margin of
Fig. 3 Clinical findings of feline leishmaniosis due to Leishmania infantum: nodular conjunctivitis (upper eyelid) and ulcerative dermatitis
Pennisi et al. Parasites & Vectors  (2015) 8:302 Page 9 of 18Clinical disease caused by natural infection with spe-
cies other than L. infantum is typically reported as nodu-
lar or ulcerative dermatitis with no systemic clinical
signs. Skin lesions are often single but they can metasta-
tize (Table 5) [73–76].
8. What are the most common dermatopathological
features of FeL?
Skin histopathology of lesions associated with L. infan-
tum has shown that the most commonly observed alter-
ation is a granulomatous dermatitis [26, 51, 56, 59, 60, 68].Fig. 4 Clinical findings of feline leishmaniosis due to Leishmania infantum:It often has a diffuse pattern and the epidermis may
present hyperkeratosis, acanthosis and ulceration [56, 68].
A nodular to diffuse arrangement of the granulomatous
dermatitis is also reported [26, 60]. However, in a retro-
spective case series from Spain, two cats presented differ-
ent histological findings [68]. The first one had
granulomatous perifolliculitis with a high number of lym-
phocytes and plasma cells surrounding the cutaneous ad-
nexa. It was associated with a marked hyperplasia of
epidermis and sebaceous glands. The other cat was diag-
nosed with a lichenoid interface dermatitis typically repre-
sented by infiltration of lymphocytes, plasma cells and aulcerative dermatitis on distal limb
Fig. 5 Clinical findings of feline leishmaniosis due to Leishmania infantum: focal alopecia and scales
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junction. In this case, epidermal necrosis and epidermal
microabscesses were also observed. A perivascular infiltra-
tion of superficial skin layers by macrophages, mast cells,
neutrophils and eosinophils was also observed in another
case [12].
Leishmania amastigotes have always been identified
in the affected skin. A semiquantitative estimation of
amastigotes was also performed with the aid ofFig. 6 Clinical findings of feline leishmaniosis due to Leishmania infantum:
left earimmunohistochemistry (IHC) [68], in which the parasitic
load of the skin ranged from high (>50 immunolabelled
amastigotes/field at x400) to moderate (10–50 immunola-
belled amastigotes/field) in cases of diffuse granulomatous
dermatitis [68]. Conversely, it was low (1–9 immunola-
belled amastigotes/field) in cases of granulomatous peri-
folliculitis or lichenoid interface dermatitis [68] .
In biopsy samples taken from cases with ulcerative
dermatitis, eosinophilic granulomatous dermatitis with asymmetrical alopecia on pinnae and acral thickening of the margin of
Table 5 Clinical cases of feline leishmaniosis caused by species other than Leishmania infantum
Leishmania species Geographic location Signalment Lesions and outcome Reference
L. amazonensis Brazil 2-year-old female Single, nodular lesion (2 cm in diameter) on the
nose and many nodules of different sizes on the
ears and digital regions; smears from lesion
aspirates with numerous amastigotes. Respiratory
failure and euthanasia some days after diagnosis
[73]
L. braziliensis Brazil 4-year-old female Cutaneous ulcer (0.5 cm in diameter) present for
6 months on the nose, enlargement of the planum
nasale and two additional ulcers on the left face
(0.3 cm in diameter each). Good general condition.
Outcome not reported
[74]
5-year-old female Papule on the bridge of the nose and vegetating
lesion on the nasal mucosa for 3 months. Good
general condition. Outcome not described
French Guiana 3 to 5-year-old female Cutaneous ulcer (1 cm in diameter) on the nose
(for ~8 month) and nodules of different sizes on
the ears. Outcome not reported
[93]
L. mexicana USA (Texas) Immunocompetent long-haired
adult male followed up for 7 years
Four large (4–7 mm) and many small nodules
initially confined to the left ear; lesions with
numerous amastigote forms
[75]
Two years after a radical pinnectomy, the animal
had lesion recurrence at the stump, and lesions
later developed on the muzzle and nasal mucosa;
treatment was attempted several times, but with
no resolution
USA (Texas) 8 domestic cats (5 males and
3 females) aged 1 to 11 years old
(median: 3 years)
One or multiple nodules on the pinnae and less
commonly on the muzzle and periorbital skin,
with variably ulcerated, scaled or smooth
surfaces (histology: numerous amastigotes)
[76]
Two cats had recurrent cutaneous leishmaniosis:
one was treated with allopurinol, but the skin
lesions continued to recur despite treatment;
in three other cats, excisional biopsy was
apparently curative, and lesions did not recur
during the follow-up period (2–4 years)
L. venezuelensis Venezuela
(Lara state)
4 cats One cat: nodular lesion (2 cm) on the nose and
six smaller nodules on the ears; two cats: single
nodules (2–3 cm) on the nose; one cat: single
nodule on the nose (2–3 cm) and 3 months
afterwards presented with metastatic new
lesions on the ears, tail and lower limbs
[105]
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the presence of amastigotes, but with a positive quantita-
tive Leishmania PCR [62].
In some FeL cases, other dermatological diseases such
as eosinophilic granuloma and PF were also diagnosed
[52, 56, 68].
Interestingly, amastigotes were also found associated
with neoplastic tissue in the lesion of two cats with
squamous cell carcinoma (SCC) [13]. In one other case,
SCC was diagnosed in a cat presenting concurrent Leish-
mania skin lesions [14, 59].
In two cases of skin disease caused by L. braziliensis, a
mononuclear and neutrophilic inflammatory infiltrate of
the dermal tissue was seen in histological sections [77].
9. What are the most common differential diagnoses in
L. infantum endemic areas for dermatological features?The commonly seen cutaneous nodular form in FeL
cases should be distinguished from nodules caused in
cats with cryptococcosis, sporotrichosis, histoplasmo-
sis, sterile or eosinophilic granuloma, mycobacter-
ioses, and a wide variety of cutaneous neoplasms (e.g.
feline sarcoids, mast cell tumor, fibrosarcoma, basal
cell carcinoma, bowenoid in situ carcinoma and
lymphoma). The main differentials of the ulcerative le-
sions include squamous cell carcinoma with which
however it may co-exist [13, 14, 59], idiopathic
ulcerative dermatitis, indolent ulcer, mosquito-bite
dermatitis, atypical mycobacteriosis and feline leprosy,
cutaneous vasculitis, erythema multiforme and cold-ag-
glutinin disease. Finally, skin diseases such as dermato-
phytosis, systemic or cutaneous lupus erythematosus,
exfoliative dermatitis due to thymoma or due to immune-
mediated pathomecanisms, PF, sebaceous adenitis/mural
Pennisi et al. Parasites & Vectors  (2015) 8:302 Page 12 of 18folliculitis complex and paraneoplastic alopecia could be
included in the differential list of those leishmanial cats
that are admitted with the rare exfoliative/crusting derma-
titis which may also be alopecic and erythematous. It has
been postulated that PF and FeL may share a common
pathomechanism (molecular mimicry) when they co-exist
in the same cat [56].
10. What clinicopathological findings may alert the
clinician to the possibility of FeL due to L. infantum?
Limited information is available about clinicopath-
ological abnormalities in cats and it is only based on
case reports. Mild to severe normocytic normochro-
mic non-regenerative anemia is the most frequent
haematological abnormality reported in clinical cases
[37]. Moderate to severe pancytopenia may be ob-
served [37, 50, 57] in association with aplastic bone
marrow, but some of the cats reported with pancyto-
penia were FIV positive [37, 50, 57]. Curiously, in
one of these cases, amastigotes were found in 4 % of
neutrophils in buffy coat smears [57].
Hyperproteinemia with hypergammaglobulinemia
is a common finding in FeL as also found in dogs
[2], and hypoalbuminemia is occasionally reported
[37, 50].
Renal proteinuria and increased serum creatinine are
also reported at diagnosis or during follow-up in some
cases [37, 68].
Relative lymphocytosis and an increase in serum ALT
activity were significantly associated with seroreactivity
to L. infantum [78].Fig. 7 Fine-needle aspirate of a reactive lymph node from a cat with feline
a macrophage with L. infantum amastigotes (red arrows). May-Grünwald-GiThe type of inflammatory infiltrate found in tissue cy-
tology (aspirates, impression smears) or histopathology
in organs such as skin, eye, oral mucosa, liver, spleen
and kidney is commonly pyogranulomatous to granu-
lomatous [66, 68, 72]. There was also lymphoid reactive
hyperplasia in lymphoid organs such as lymph nodes
[79] and spleen [57], with variable numbers of Leish-
mania amastigotes observed (Fig. 7).
11. What are the most common differential diagnoses
in endemic areas for systemic illness caused by
L. infantum in cats?
As lymph node enlargement is the most common sign,
apart from skin and mucocutaneous lesions, FeL should
be included in the differential list when this finding is
noted on physical examination as solitary or generalized
lymphadenomegaly. This list mainly includes infections
with other infectious agents (FIV, FeLV, FCoV, Barto-
nella, Mycobacteria, T. gondii, Cryptococcus or other sys-
temic mycoses), lymphoma or metastatic involvement
from other neoplasia.
FeL should also be considered in cats with ophthal-
mologic disease, mainly in cats with acute, recurring or
chronic uveitis and differentiated from similar clinical
conditions caused by FIV, FeLV, FCoV, Bartonella, T.
gondii, fungal infections, neoplasia or paraneoplastic
syndrome. Some feline uveitis cases are considered
idiopatic and treated with corticosteroids. A diagnosis
of idiopatic uveitis was initially made in some cases of
ocular FeL and corticosteroids worsened the disease
[50, 55, 69]. This fact warrants a careful investigationleishmaniosis due to Leishmania infantum: lymphoid hyperplasia and
emsa stain, scale bar = 20 μm
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corticosteroids.
Proliferative and ulcerative chronic inflammation of
the oral mucosa associated with FeL can be included in
the list of possible causes of the feline chronic gingivos-
tomatitis syndrome (FCGS). This painful and common
immune-mediated disease is considered multifactorial in
cats and treated by full mouth teeth extraction for elim-
inating oral plaque antigenic stimulation. Corticosteroids
are frequently used to improve the clinical signs; how-
ever, when this was tried in some cats with oral disease
associated with L. infantum infection it induced worsen-
ing of FeL [11, 66].
Hyperglobulinemia with increased gammaglobulin
level reported in FeL is usually found in chronic infec-
tions caused by viruses, bacteria or systemic fungi, or in-
flammation associated with FCGS or inflammatory
bowel disease, or in neoplasia such as lymphoma, or
multiple myeloma.
Diagnosis
12. On what tests should the evaluation of L. infantum
infection be based in cats with suspected clinical
leishmaniosis?
Most diagnostic techniques for Leishmania infection
which are available for dogs are also employed in cats.
Diagnosis is made in the majority of cases by serologic,
cytologic, histologic, culture or PCR methods (Table 6).
The most common serological test used appears to be
the immunoflurescence antibody test (IFAT). A validated
cut off value of 1:80 has been recommended in catsTable 6 Laboratory methods for diagnosis of Leishmania infection i
Method Principle Features
Serology Detection of specific antibodies by




clinical cases may have
positive antibody levels
usually diagnostic
Cytology Detection of amastigotes in stained
tissue smears (ex: lymph node, bone









IHC is not widely availa
Culture Multiplication of promastigotes from
tissues
Not suitable for rapid d
not widely available
PCR Amplification of parasite DNA from
tissues and biological fluids, including
blood, buffy coat, bone marrow, lymph
nodes and conjunctival swabs
More sensitive than cyt
with IHC; may allow mo
characterization and qu
the parasitic load
DAT: direct agglutination test; ELISA: enzyme-linked immunosorbent assay; IFAT: im
chain reaction; WB, western blottested by this serological technique and the serum anti-
body level to Leishmania antigen ranged from low to
high positive levels in clinical cases of FeL [24]. Quanti-
tative enzyme-linked immunosorbent assays (ELISA) are
also frequently employed and seems to be more sensitive
than IFAT [80–82]. The direct agglutination test (DAT)
was found less sensitive than IFAT [27] or ELISA [23]
and western blot (WB) was more sensitive than IFAT
[83].
Clinical cases of FeL with positive sera have specific
antibodies against L. infantum antigens of low mo-
lecular mass (≤31 kDa) [12, 22] by WB. These low mo-
lecular mass antigens are considered to be also the
most specific polypeptides in the diagnosis of human
[84, 85] and CanL [86, 87]. It is important to highlight
that cats from both endemic and non endemic areas
may be positive against high molecular weight anti-
gens. This is also observed in dogs and humans and it
is considered as a cross-reaction probably due to the
presence of antibodies to the heat shock protein 70
family [22].
In general, anti-Leishmania antibodies should always
be evaluated by laboratories using serological methods
validated in cats.
Cross-reactions exist between feline antibodies to
different Leishmania and Trypanosoma species as also
shown in dogs, but they do not seem to occur with
antibodies to T. gondii [28, 66].
Amastigotes were found in blood smears and
smears from nasal exudate or corneal cytology [50,
57, 63, 66].
The diagnostic procedure in cats positive to Leish-




from low to high
, but the latter are
Antibodies should be evaluated
using techniques validated in cats;
parasitological methods should be
employed in clinically suspect but
seronegative or low positive cats
[23–25,
82–84]
ming and For compatible skin or mucosal lesions,
enlarged lymph nodes and other
lesions, and for clinically suspected




ming and [59, 68,
69, 72]
ble






Preferable to sample more than one
tissue, in order to increase sensitivity of




munofluorescence antibody test; IHC: immunohistochemistry; PCR: polymerase
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rent diseases.
13. Should healthy cats or cats under specific
conditions be tested for L. infantum infection?
Leishmania infantum can infect apparently healthy
cats, and as with dogs, infection may persist with no
clinical manifestations [88]. Since cats infected with
L. infantum may not be sick and, therefore, not
present any clinical signs, it is questionable whether
healthy cats should be tested for this infection. In
our opinion, cats with no clinical signs and/or clini-
copathological abnormalities compatible with leish-
maniosis should be tested for Leishmania infection if
they are used as blood donors, since it has been
shown for humans and dogs that blood products
from infected individuals may transmit infection [89].
Antibody testing and blood PCR are advisable as in-
dicated for dogs. Furthermore, testing can be done
for exportation purposes to countries where
leishmaniosis is not endemic and may require cats to
be tested for infection before importation. Finally,
cats with clinical conditions requiring immunosup-
pressive therapies should be preliminarily tested in
endemic areas, as clinical cases of FeL were diag-
nosed in cats under long term immunosuppressive
treatment.
Treatment and monitoring
14. What is the most effective specific treatment and
the expected clinical response to treatment of FeL
due to L. infantum?
The published information on the treatment of FeL
is extremely limited because it is available from only
20 case reports and only some of them were followed
up (Table 7). Allopurinol is the most frequently usedTable 7 Therapeutic regimens used in cats affected by feline leishm
Drug and dosage Duration
Allopurinol (10–15 mg/kg/12 h, 20 mg/kg/24 h,
25 mg/cat/12 h, 100 mg/cat/24 h) PO
6 months -
Meglumine antimoniate (20–50 mg/kg/24 h SC) 20–30 days
Meglumine antimoniate (175 mg/cat/48 h IM) 55 days
Meglumine antimoniate (5 mg/kg/24 h SC) in
combination with Ketoconazole (10 mg/kg/24 h PO)
3 cycles of 4
10 days apa
Fluconazole (5 mg/kg/24 h PO) 60 days
Spiramycin (150.000 IU/kg) and Metrodinazole
(25 mg/kg) 24 h PO
35 days
Itraconazole (50 mg/cat/24 h PO) 60 days
SC: subcutaneous; IM: intamuscular; PO: per os a a same cat was treated with the thdrug followed by meglumine antimoniate, but infor-
mation is lacking on pharmacokinetic and pharmaco-
dynamic characteristics of these drugs in cats and also
about their safety.
Allopurinol is generally well tolerated; however, in
one cat, elevation of hepatic enzymes was reported at
10 mg/kg BID and the dose was reduced to 5 mg/kg
BID [56]. Clinical improvement was observed in most
cases treated with allopurinol – even in FIV positive
cats –within a few weeks after treatment was initated
[37, 50, 64] or slowly after 6 months [56]. A long
term follow-up was available in some cats treated
with allopurinol. A clinical cure was obtained in
these cats but relapse occurred after discontinuation
of treatment, suggesting that they were still infected
[14, 37, 55]. Clinical worsening leading to euthanasia
occurred in a few cases after a few weeks of therapy
[54, 57].
Clinical cure was generally obtained in the few cats
that were treated with meglumine antimoniate, but
long term follow up are not available from these cases.
Some other oral drugs (fluconazole, itraconazole,
metronidazole and spiramycin) administered to one cat
at different times were considered as not effective [37].
Surgical removal of cutaneous nodules (performed
in two cats) was followed by relapsing of cutaneous
lesions [36, 51].
In conclusion, currently, no scientific evidence con-
cerning the best treatment for FeL is available, but
more extensive clinical experience is available for
treatment with allopurinol (10 mg/kg BID or 20 mg/
kg SID). The drug of choice to be used in FeL should
nevertheless be based on the best compliance and
safety for the cat with the alternatives of long term
oral drug treatment (allopurinol) or a parenteral
therapy (meglumine antimoniate). As there are no
studies on the safety of these drugs in cats, it is rec-
ommended to strictly monitor the health status of
animals under treatment by means of regular check-aniosis
Number of treated cats References










ree different therapeutic regimens at subsequent times
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promptly report any abnormality.
The duration of allopurinol treatment should be
evaluated case by case based on clinical response and
on parasitological and serological monitoring.
Prognosis
15. What is the prognosis of clinical leishmaniosis ?
Some consideration can be extrapolated from informa-
tion reported on 14 cats affected by FeL and followed up
until death or euthanasia. On the basis of these reported
cases, prognosis appears to vary from good to poor. In
fact, five cats died a few days or weeks after diagnosis
[12, 26, 36, 37, 65]. Some were affected by chronic renal
failure or hepatic disease, but the real influence of Leish-
mania infection on mortality was not clearly demon-
strated in these cases [36, 37, 65]. In other cases,
euthanasia was performed after diagnosis because of a
rapid clinical worsening [54, 57, 62] or due to a concur-
rent neoplasia [13]. Post mortem evaluation was obtained
in three cats that died or were euthanized shortly after
diagnosis, and all of them had visceral dissemination of
Leishmania amastigotes found in the spleen, lymph
nodes, liver, stomach or in the large bowel [13, 36, 57].
Records of a long-term follow up (13–60 months) are
available for nine cats and in four of the cases they were
followed up until death or euthanasia [11, 37, 50, 56, 60,
66, 69, 70]. Their age ranged between 5 and 12 years at
diagnosis and only one had been found positive for FIV
antibodies. Clinical presentation varied but visceral dis-
semination of Leishmania infection was investigated and
confirmed in all but one case. This latter cat had a diag-
nosis of PF associated with Leishmania infection con-
firmed by serology and PCR on skin biopsies, but the
potential extra-cutaneous dissemination of infection was
not investigated [56]. Four of these followed up cats
were treated with allopurinol for 24–40 months [37, 50,
56, 66].
It is noteworthy that three cats which were never
treated with anti-Leishmania drugs after diagnosis died
or were euthanized 1–5 years later and one was reported
alive after 4 years. In these untreated cases, FeL pro-
gressed with time and chronic renal disease developed in
two cats that were not treated. Untreated ocular FeL
may cause vision loss and may require ocular enucle-
ation due to panophthalmitis [50, 53, 55, 68, 69].
The retrospective evaluation of single case reports did
not provide clear evidence about the prognosis of FeL
because the clinical data available are heterogeneous and
sometimes incomplete; however, some conclusions can
be inferred. Both treated and untreated cats may live for
years before the deterioration of their health statusmainly due to renal and heart injuries that might be un-
related to L.infantum infection. The exact role of L.
infantum infection in the development of multiorgan in-
jury causing renal, cardiac or hepatic disease has to be
confirmed. However, it can significantly influence life ex-
pectancy and any concurrent diseases should be treated
if detected. In case of renal disease, the International
Renal Interest Society (IRIS) staging system is recom-
mended for therapy, follow-up and prognosis (http://
www.iris-kidney.com).
Prevention
16. Can Leishmania infection be prevented in cats?
There are two main reasons for employing preventive
measures against L. infantum infection in a susceptible
animal host and suspected reservoir such as the cat: 1)
to protect the single animal from the risk of developing
a clinical disease; 2) and to contribute to the reduction
of the prevalence of infection in a geographic area. How-
ever, it should be also pointed out that the epidemio-
logical role of the cat as a main reservoir for Leishmania
species has not been confirmed [34].
Due to the absence of studies on vaccines against
Leishmania in cats, the best strategy to prevent Leish-
mania infection in this animal could be to use topical
insecticides with application of chemical compounds
with sand fly repellent activity, similar to those used for
dogs. Unfortunately, most pyrethroids, like permethrin
and deltamethrin, cannot be used in cats due to their
toxicity to this species. The recent launch of a collar
containing an additional compound belonging to this
chemical class, flumethrin, that is well tolerated in the
cat might represent a valid preventive option for the in-
dividual reduction of risk for infection of cats in highly
endemic areas of leishmaniosis, and for limiting the in-
fectiousness of those that are already infected. In fact,
this collar was found useful in reduction of the incidence
of L. infantum infection in dogs [90, 91].
Conclusions
Although the data on FeL supported by consolidated
evidence-based studies are limited, these guidelines con-
stitute a baseline for educating and informing feline
practitioners with the most comprehensive and updated
data set on this important neglected feline protozoal
disease.
Further studies need to elucidate gaps in knowledge
on this infection in cats and to provide evidence-based
information on the management of this disease.
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